Clinical trial
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in…
NCT00039377 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00039377 |
|---|---|
| Title | Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
| Official title | A Phase II Trial of Sequential Chemotherapy, Imatinib Mesylate (Gleevec, STI571) (NSC # 716051), and Transplantation for Adults With Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia by the CALGB and SWOG |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Acute Lymphoblastic Leukemia in Remission |
| Intervention type | Biological, Drug, Other, Procedure, Radiation |
| Interventions | imatinib mesylate, methotrexate, vincristine sulfate, leucovorin calcium, peripheral blood stem cell transplantation, autologous hematopoietic stem cell transplantation, allogeneic hematopoietic stem cell transplantation, total-body irradiation, tacrolimus, filgrastim and 4 more |
| Enrollment | 58 |
| Start date | Apr 1, 2002 |
| Primary completion | Apr 1, 2012 |
| Completion | Feb 1, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 24, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: